We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Curious about Xylem (XYL) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Xylem (XYL - Free Report) will report quarterly earnings of $1.06 per share in its upcoming release, pointing to a year-over-year increase of 8.2%. It is anticipated that revenues will amount to $2.16 billion, exhibiting an increase of 25.2% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.9% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Xylem metrics that are commonly tracked and forecasted by Wall Street analysts.
The consensus estimate for 'Revenue- Applied Water' stands at $453.47 million. The estimate suggests a change of -5.1% year over year.
According to the collective judgment of analysts, 'Revenue- Water Infrastructure' should come in at $637.81 million. The estimate indicates a year-over-year change of -9.4%.
Analysts forecast 'Revenue- Measurement & Control Solutions' to reach $470.39 million. The estimate points to a change of +13.4% from the year-ago quarter.
Analysts expect 'Adjusted Operating Income- Water Infrastructure' to come in at $118.29 million. Compared to the current estimate, the company reported $129 million in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Adjusted Operating Income- Applied Water' will likely reach $65.76 million. The estimate is in contrast to the year-ago figure of $86 million.
Analysts predict that the 'Adjusted Operating Income- Measurement & Control Solutions' will reach $82.93 million. Compared to the present estimate, the company reported $46 million in the same quarter last year.
Over the past month, shares of Xylem have returned +3.8% versus the Zacks S&P 500 composite's -0.2% change. Currently, XYL carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Curious about Xylem (XYL) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Xylem (XYL - Free Report) will report quarterly earnings of $1.06 per share in its upcoming release, pointing to a year-over-year increase of 8.2%. It is anticipated that revenues will amount to $2.16 billion, exhibiting an increase of 25.2% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.9% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Xylem metrics that are commonly tracked and forecasted by Wall Street analysts.
The consensus estimate for 'Revenue- Applied Water' stands at $453.47 million. The estimate suggests a change of -5.1% year over year.
According to the collective judgment of analysts, 'Revenue- Water Infrastructure' should come in at $637.81 million. The estimate indicates a year-over-year change of -9.4%.
Analysts forecast 'Revenue- Measurement & Control Solutions' to reach $470.39 million. The estimate points to a change of +13.4% from the year-ago quarter.
Analysts expect 'Adjusted Operating Income- Water Infrastructure' to come in at $118.29 million. Compared to the current estimate, the company reported $129 million in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Adjusted Operating Income- Applied Water' will likely reach $65.76 million. The estimate is in contrast to the year-ago figure of $86 million.
Analysts predict that the 'Adjusted Operating Income- Measurement & Control Solutions' will reach $82.93 million. Compared to the present estimate, the company reported $46 million in the same quarter last year.
View all Key Company Metrics for Xylem here>>>
Over the past month, shares of Xylem have returned +3.8% versus the Zacks S&P 500 composite's -0.2% change. Currently, XYL carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>